Pradžia › Endometrio vėžys
Endometrio vėžys klinikiniai tyrimai JAV ieško dalyvių
168 tyrimai dėl Endometrio vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX68 tyrimai
- New York City, NY52 tyrimai
- Boston, MA50 tyrimai
- Arlington, VA39 tyrimai
- Nashville, TN38 tyrimai
- Los Angeles, CA34 tyrimai
- St. Louis, MO29 tyrimai
- Philadelphia, PA28 tyrimai
- San Antonio, TX27 tyrimai
- Queens, NY25 tyrimai
- Columbus, OH25 tyrimai
- Chicago, IL25 tyrimai
- Oklahoma City, OK25 tyrimai
- Dallas, TX24 tyrimai
- Portland, OR24 tyrimai
- Pittsburgh, PA23 tyrimai
- Detroit, MI21 tyrimas
- Cleveland, OH20 tyrimai
- Rochester, MN20 tyrimai
- Edison, NJ19 tyrimai
- Washington, DC18 tyrimai
- Minneapolis, MN18 tyrimai
- Grand Rapids, MI18 tyrimai
- Orlando, FL17 tyrimai
- Atlanta, GA17 tyrimai
- Seattle, WA17 tyrimai
- Baldwin Park, CA17 tyrimai
- Durham, NC16 tyrimai
- Miami, FL16 tyrimai
- Birmingham, AL16 tyrimai
- San Diego, CA16 tyrimai
- Austin, TX15 tyrimai
- Denver, CO15 tyrimai
- Tampa, FL15 tyrimai
- Sarasota, FL15 tyrimai
- New Haven, CT14 tyrimai
- Providence, RI14 tyrimai
- Salt Lake City, UT14 tyrimai
- Indianapolis, IN14 tyrimai
- Aurora, CO14 tyrimai
Pagal valstiją
- Aidahas4 tyrimai
- Ajova10 tyrimai
- Alabama19 tyrimai
- Aliaska4 tyrimai
- Arizona22 tyrimai
- Arkansas12 tyrimai
- Delaveras4 tyrimai
- Džordžija24 tyrimai
- Florida65 tyrimai
- Havajai3 tyrimai
- Ilinoisas38 tyrimai
- Indianas19 tyrimai
- Kalifornija73 tyrimai
- Kanzasas5 tyrimai
- Kentukis10 tyrimai
- Koloradas30 tyrimai
- Kolumbijos apskritis10 tyrimai
- Konektikutas20 tyrimai
- Luiziana15 tyrimai
- Masčusetsas53 tyrimai
- Menas7 tyrimai
- Merilendas22 tyrimai
- Minesota39 tyrimai
- Misisipė5 tyrimai
- Misūris31 tyrimas
- Mičiganas43 tyrimai
- Montana5 tyrimai
- Nebraska10 tyrimai
- Nevada8 tyrimai
- New Jersey32 tyrimai
- New Mexico13 tyrimai
- New York69 tyrimai
- North Carolina31 tyrimas
- North Dakota6 tyrimai
- Ohio50 tyrimai
- Oklahoma28 tyrimai
- Oregon27 tyrimai
- Pennsylvania42 tyrimai
- Rhode Island14 tyrimai
- South Carolina9 tyrimai
- South Dakota11 tyrimai
- Tennessee41 tyrimas
- Texas91 tyrimas
- Utah25 tyrimai
- Virginia51 tyrimas
- Washington20 tyrimai
- West Virginia4 tyrimai
- Wisconsin24 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Tirzepatide in Obesity-Driven Endometrial Cancer
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-02 · NCT07065552Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Renkami dalyviai2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-02 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07059884A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-02 · NCT07286331A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-02 · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07419841Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Renkami dalyviai2 fazė
Amžius nuo 18 iki 72 · Visoms lytims · Atnaujinta 2026-10-02 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07285044A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-29 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-28 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT05867251DESTINY-PANTUMOUR04
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06218914ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Renkami dalyviai
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-25 · NCT07270666Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-25 · NCT03564340Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-24 · NCT07594015A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-24 · NCT04590326Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.